{"id":231521,"date":"2026-02-17T14:03:53","date_gmt":"2026-02-17T20:03:53","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/one-injection-permanent-glp-1-the-future-of-weight-loss-metabolic-therapy"},"modified":"2026-02-17T14:03:53","modified_gmt":"2026-02-17T20:03:53","slug":"one-injection-permanent-glp-1-the-future-of-weight-loss-metabolic-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/one-injection-permanent-glp-1-the-future-of-weight-loss-metabolic-therapy","title":{"rendered":"One Injection. Permanent GLP-1? The Future of Weight Loss &amp; Metabolic Therapy"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/231521?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>A company called Fractal Health is developing a one-time GLP-1 gene therapy and the first humans are being dosed this year.<\/p>\n<p>Instead of weekly injections like semaglutide or tirzepatide, this approach delivers genes directly into pancreatic beta cells. The therapy is controlled by the insulin promoter, meaning GLP-1 is only released when you eat \u2014 not continuously.<\/p>\n<p>That could mean fewer systemic side effects and a more physiologic response.<\/p>\n<p>They\u2019re developing two versions:<br \/> \u2022 GLP-1 alone.<br \/> \u2022 GLP-1 + GIP (similar to tirzepatide) <\/p>\n<p>One injection. Potentially permanent metabolic support.<\/p>\n<p>If this works, it could redefine obesity and diabetes treatment.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/02\/one-injection-permanent-glp-1-the-future-of-weight-loss-metabolic-therapy\">Continue reading \u201cOne Injection. Permanent GLP-1? The Future of Weight Loss &amp; Metabolic Therapy\u201d | &gt;<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A company called Fractal Health is developing a one-time GLP-1 gene therapy and the first humans are being dosed this year. Instead of weekly injections like semaglutide or tirzepatide, this approach delivers genes directly into pancreatic beta cells. The therapy is controlled by the insulin promoter, meaning GLP-1 is only released when you eat \u2014 [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-231521","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231521"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231521\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}